Po Hu

1.3k total citations
35 papers, 1.1k citations indexed

About

Po Hu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Po Hu has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Po Hu's work include Calcium signaling and nucleotide metabolism (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Po Hu is often cited by papers focused on Calcium signaling and nucleotide metabolism (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Po Hu collaborates with scholars based in China, United States and Australia. Po Hu's co-authors include Yingkai Zhang, Shenglong Wang, Xiaoxuan Yu, Qinglong Guo, Hui Hui, Clémence Corminbœuf, Mark E. Tuckerman, Suse Broyde, Lihua Wang and Jingyan Xu and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and The Science of The Total Environment.

In The Last Decade

Po Hu

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po Hu China 18 698 147 113 112 96 35 1.1k
Piia Kokkonen Czechia 12 665 1.0× 57 0.4× 40 0.4× 94 0.8× 136 1.4× 15 953
Flavio Rocco Italy 22 877 1.3× 198 1.3× 52 0.5× 241 2.2× 77 0.8× 46 1.6k
Zhongliang Zheng China 16 553 0.8× 196 1.3× 33 0.3× 75 0.7× 105 1.1× 31 828
Francisca Barceló Spain 22 1.1k 1.6× 166 1.1× 40 0.4× 193 1.7× 37 0.4× 51 1.6k
Colin G. Ferguson United States 14 784 1.1× 65 0.4× 65 0.6× 181 1.6× 58 0.6× 19 1.3k
Yiqin Wu United States 19 1.3k 1.9× 222 1.5× 78 0.7× 302 2.7× 50 0.5× 37 1.6k
Jacopo Sgrignani Italy 22 611 0.9× 228 1.6× 96 0.8× 214 1.9× 120 1.3× 61 1.2k
Jingwu Kang China 24 535 0.8× 62 0.4× 133 1.2× 61 0.5× 53 0.6× 83 1.4k
Parthiban Marimuthu Finland 13 512 0.7× 75 0.5× 60 0.5× 108 1.0× 83 0.9× 41 839
Goutam Mukherjee India 22 479 0.7× 111 0.8× 48 0.4× 481 4.3× 112 1.2× 67 1.5k

Countries citing papers authored by Po Hu

Since Specialization
Citations

This map shows the geographic impact of Po Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po Hu more than expected).

Fields of papers citing papers by Po Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po Hu. The network helps show where Po Hu may publish in the future.

Co-authorship network of co-authors of Po Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Po Hu. A scholar is included among the top collaborators of Po Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po Hu. Po Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Dehui, et al.. (2025). Validated herbal extracts for alleviating chemotherapy-induced myelosuppression: A systematic review and meta-analysis. Phytomedicine. 141. 156659–156659. 1 indexed citations
2.
Hu, Po, et al.. (2024). Telomerase reverse transcriptase gene knock‐in unleashes enhanced longevity and accelerated damage repair in mice. Aging Cell. 24(4). e14445–e14445. 5 indexed citations
3.
Chen, Jie, et al.. (2024). Saloplastics based on protein-peptides complexes immobilizing organic molecules in gastrointestinal drug delivery for ulcerative colitis treatment. International Journal of Biological Macromolecules. 281(Pt 1). 136077–136077. 1 indexed citations
4.
Wang, Tianyi, et al.. (2023). Lysosomal dysfunction in carbon black-induced lung disorders. The Science of The Total Environment. 905. 167200–167200. 7 indexed citations
5.
Wang, Xinzhu, et al.. (2023). Optimization of Neferine Purification Based on Response Surface Methodology and Its Anti-Metastasis Mechanism on HepG2 Cells. Molecules. 28(13). 5086–5086. 2 indexed citations
6.
Guo, Yongjian, Po Hu, Hui Li, et al.. (2023). Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies. Clinical and Translational Medicine. 13(3). e1229–e1229. 7 indexed citations
7.
Zhong, Lei, et al.. (2022). Quercetin promotes cutaneous wound healing in mice through Wnt/β-catenin signaling pathway. Journal of Ethnopharmacology. 290. 115066–115066. 85 indexed citations
8.
Hu, Po, Peng Wan, Anna Xu, et al.. (2022). Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 149(2). 553–566. 3 indexed citations
9.
Li, Hui, Po Hu, Xiangyuan Wang, et al.. (2021). One‐Two Punch Therapy for the Treatment of T‐Cell Malignancies Involving p53‐Dependent Cellular Senescence. Oxidative Medicine and Cellular Longevity. 2021(1). 5529518–5529518. 10 indexed citations
10.
Hu, Po, Hui Li, Hongzheng Wang, et al.. (2021). Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy: Dynamic analysis on cytotoxic effects of LW-218. Acta Pharmaceutica Sinica B. 11(10). 3178–3192. 23 indexed citations
11.
Hu, Po, Jubo Wang, Hui Li, et al.. (2021). FV-429 induces autophagy blockage and lysosome-dependent cell death of T-cell malignancies via lysosomal dysregulation. Cell Death and Disease. 12(1). 80–80. 31 indexed citations
12.
Wang, Xiangyuan, Hongzheng Wang, Po Hu, et al.. (2021). Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia. Cell Communication and Signaling. 19(1). 83–83. 9 indexed citations
13.
Yu, Xiaoxuan, Hui Li, Po Hu, et al.. (2020). Involvement of p53 Acetylation in Growth Suppression of Cutaneous T-Cell Lymphomas Induced by HDAC Inhibition. Journal of Investigative Dermatology. 140(10). 2009–2022.e4. 22 indexed citations
14.
Wang, Han, Xuan Zhao, Minyue Chen, et al.. (2020). The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN). Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(8). 118707–118707. 14 indexed citations
15.
Li, Hui, Po Hu, Zhanyu Wang, et al.. (2019). Mitotic catastrophe and p53-dependent senescence induction in T-cell malignancies exposed to nonlethal dosage of GL-V9. Archives of Toxicology. 94(1). 305–323. 17 indexed citations
16.
Hu, Po, Hui Li, Xiaoxuan Yu, et al.. (2019). LW-213, a newly synthesized flavonoid, induces G2/M phase arrest and apoptosis in chronic myeloid leukemia. Acta Pharmacologica Sinica. 41(2). 249–259. 8 indexed citations
17.
Fahie, Kamau, Po Hu, Stephen Swatkoski, et al.. (2009). Side chain specificity of ADP‐ribosylation by a sirtuin. FEBS Journal. 276(23). 7159–7176. 25 indexed citations
18.
Wang, Shenglong, Po Hu, & Yingkai Zhang. (2007). Ab Initio Quantum Mechanical/Molecular Mechanical Molecular Dynamics Simulation of Enzyme Catalysis:  The Case of Histone Lysine Methyltransferase SET7/9. The Journal of Physical Chemistry B. 111(14). 3758–3764. 66 indexed citations
19.
Liu, Zhigang, Anne W. Young, Po Hu, et al.. (2007). Tuning the Membrane Selectivity of Antimicrobial Peptides by Using Multivalent Design. ChemBioChem. 8(17). 2063–2065. 53 indexed citations
20.
Hu, Po & Yingkai Zhang. (2006). Catalytic Mechanism and Product Specificity of the Histone Lysine Methyltransferase SET7/9:  An ab Initio QM/MM-FE Study with Multiple Initial Structures. Journal of the American Chemical Society. 128(4). 1272–1278. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026